Related Experiment Video
Updated: Sep 26, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and
Ravikumar Rallapalli1, Gordon Strachan, Rocky S Tuan
1Department of Pathology, University of Pennsylvania School of Dental Medicine, 4010 Locust St, Rm 312 Levy Research, Philadelphia, Pennsylvania 19104-6002, USA.
Abstract:
The MDMX gene product is related to the MDM2 oncoprotein, both of which interact with the p53 tumor suppressor. A novel transcript of the MDMX gene has been previously identified that has a short internal deletion of 68 base pairs, producing a shift in the reading frame after codon 114, resulting in the inclusion of 13 novel amino acids (after residue 114) followed by a stop codon at amino acid residue 127. This truncated MDMX protein, termed MDMX-S, represents only the p53 binding domain and binds and inactivates p53 better than full-length MDMX or MDM2. Here we show that when expressed in cells, MDMX-S is targeted more efficiently to the nucleus than MDMX. MDMX-S suppresses p53-mediated transcription from a p53 target promoter better than full-length MDMX. The DNA damage inducibility of these p53 responsive promoters was suppressed better by MDMX-S than by MDMX. Analysis of the MDMX-S protein indicated that the 13 novel amino acids at its carboxy terminus was responsible for high affinity binding to p53 in vitro and for high level expression of the protein in cells. Deletion of this 13 amino acid sequence resulted in a protein that was not able to bind p53 and was not able to be expressed well in cells. Taken together, these data point to an important domain within MDMX-S that enables it to function well in vivo to block p53 activity. Published 2003 Wiley-Liss, Inc.
Insights
A novel truncated MDMX-S protein binds and inactivates the p53 tumor suppressor more effectively than full-length MDMX. This enhanced activity is due to a unique 13-amino acid sequence, crucial for p53 binding and expression.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Biochemistry
Background:
- MDMX and MDM2 are oncoproteins that regulate the p53 tumor suppressor.
- A previously identified MDMX transcript results in a truncated protein, MDMX-S.
Purpose of the Study:
- To investigate the functional properties of the truncated MDMX-S protein.
- To determine the role of novel amino acids in MDMX-S activity.
Main Methods:
- Expression of MDMX-S in cellular models.
- Assessment of nuclear localization and p53 binding affinity.
- Analysis of p53-mediated transcription suppression.
Main Results:
- MDMX-S exhibits enhanced nuclear targeting compared to full-length MDMX.
- MDMX-S more potently suppresses p53-mediated transcription and DNA damage inducibility.
- A 13-amino acid sequence in MDMX-S is essential for high-affinity p53 binding and protein expression.
Conclusions:
- MDMX-S possesses a critical domain responsible for its potent inhibition of p53 activity.
- The novel amino acid sequence significantly contributes to MDMX-S's in vivo function.
- MDMX-S represents a potent inhibitor of p53, with implications for cancer therapy research.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Epigenetic Regulation
Master Transcription Regulators
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

